GRI Bio, Inc. (GRI)
1.80
-0.03
(-1.64%)
USD |
NASDAQ |
Nov 12, 16:00
1.80
0.00 (0.00%)
After-Hours: 18:51
GRI Bio EPS Diluted (Quarterly) : -0.9103 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.9103 |
| March 31, 2026 | -1.61 |
| December 31, 2025 | -5.343 |
| September 30, 2025 | -35.88 |
| June 30, 2025 | -36.72 |
| March 31, 2025 | -5.797 |
| December 31, 2024 | -205.63 |
| September 30, 2024 | -0.6717 |
| June 30, 2024 | -4.915 |
| March 31, 2024 | -5.943 |
| December 31, 2023 | -40.34 |
| September 30, 2023 | -47.15 |
| June 30, 2023 | -253.90 |
| March 31, 2023 | -651299.4 |
| December 31, 2022 | -3.253M |
| Date | Value |
|---|---|
| September 30, 2022 | -508993.3 |
| June 30, 2022 | -450243.8 |
| March 31, 2022 | -1055.88 |
| December 31, 2021 | -1240.62 |
| September 30, 2021 | -503.68 |
| June 30, 2021 | -926.45 |
| March 31, 2021 | -1057.08 |
| December 31, 2020 | -588.81 |
| September 30, 2020 | -418.86 |
| June 30, 2020 | -459.73 |
| March 31, 2020 | -465.36 |
| December 31, 2019 | -349.30 |
| September 30, 2019 | -380.37 |
| June 30, 2019 | -387.20 |
| March 31, 2019 | -271.74 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Anika Therapeutics, Inc. | -0.0232 |
| Savara, Inc. | -0.1691 |
| Vericel Corp. | 0.2674 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.643M |
| Total Expenses (Quarterly) | 1.643M |
| Enterprise Value | -6.902M |
| Earnings Yield | -2.43K% |
| Normalized Earnings Yield | -2430.01 |